Skip to main content
. 2022 May 9;15:465–475. doi: 10.2147/PGPM.S354011

Table 3.

Medication of the Patient at the Time of Pharmacogenetic Panel Testing

Substance Dosage Indication
Tofacitinib 5 mg 1-0-1 Rheumatoid arthritis
Prednisone 5 mg 1-0-0 Rheumatoid arthritis
Diclofenac 150 mg 0-1-0 Influenza symptoms
Ibuprofen 200 mg 1-0-1 as necessary Influenza symptoms
Dexlansoprazole 30 mg 0-1-0 as long as Ibuprofen
Vitamin D3 4500 IE/ml, 10ml 2 bottles per month Vitamin D3 deficiency